Brian Weinstein, CFA

Brian Weinstein, CFA, a medical-technology analyst at the global investment bank William Blair, Chicago. WilliamBlair.com

 

Stocks Benefit From Cancer-Test Breakthroughs
Stocks

Stocks Benefit From Cancer-Test Breakthroughs

Brian Weinstein, CFA | January 15, 2021

Genetic blood testing is a $6 billion market destined to grow to $50 billion.